pre-seed
Stage
1
Investors
About
Dia Beta Labs is a UK-based biotech company developing novel therapeutic peptides aimed at managing and reversing the progression of metabolic diseases, particularly by improving pancreatic beta-cell health to treat diabetes and obesity.
Explore Dia Beta Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.